Scientists at the Gladstone Institute of Neurological Disease (GIND) have reason to believe that reducing the level a protein, tau, can prevent the traffic jams due to Alzheimer's disease (AD) causing amyloid beta (AB) proteins.
AB proteins, which build up to toxic levels in the brains of people with AD, impair the axonal transport of these cargoes like mitochondria.
Alzheimers Disease
Alzheimer''s disease is a progressive neurodegenerative disease affecting memory and thinking and making the person increasingly dependent on others.
Advertisement
"We previously showed that suppressing the protein tau can prevent AB from causing memory deficits and other abnormalities in mouse models of AD. We wondered whether this striking rescue might be caused, at least in part, by improvements in axonal transport," explained Dr. Lennart Mucke, director and senior author of the study.
The scientists explored this possibility in mouse neurons grown in culture dishes.
Neurons from normal mice or from mice lacking one or both tau genes were exposed to human AB proteins.
![Diseases Related to Old Age]( "Diseases Related to Old Age")
Ageing is referred to the accumulation of changes that brings a person closer to death.
The AB slowed down axonal transport of mitochondria and growth factor receptors, but only in neurons that produced tau and not in neurons that lacked tau.
In the absence of the AB challenge, tau reduction had no effect on axonal transport.
"We are really excited about these results. Whether tau affects axonal transport or not has been a controversial issue, and nobody knew how to prevent AB from impairing this important function of neurons. Our study shows that tau reduction accomplishes this feat very effectively," said Dr. Keith Vossel, lead author of the study.
"Some treatments based on attacking AB have recently failed in clinical trials, and so, it is important to develop new strategies that could make the brain more resistant to AB and other AD-causing factors. Tau reduction looks promising in this regard, although a lot more work needs to be done before such approaches can be explored in humans," said Mucke.
Source: ANI
Neurons from normal mice or from mice lacking one or both tau genes were exposed to human AB proteins.
Diseases Related to Old Age
Ageing is referred to the accumulation of changes that brings a person closer to death.
Advertisement
The AB slowed down axonal transport of mitochondria and growth factor receptors, but only in neurons that produced tau and not in neurons that lacked tau.
In the absence of the AB challenge, tau reduction had no effect on axonal transport.
"We are really excited about these results. Whether tau affects axonal transport or not has been a controversial issue, and nobody knew how to prevent AB from impairing this important function of neurons. Our study shows that tau reduction accomplishes this feat very effectively," said Dr. Keith Vossel, lead author of the study.
"Some treatments based on attacking AB have recently failed in clinical trials, and so, it is important to develop new strategies that could make the brain more resistant to AB and other AD-causing factors. Tau reduction looks promising in this regard, although a lot more work needs to be done before such approaches can be explored in humans," said Mucke.
Source: ANI
Medicines Meant to Treat Alzheimers Found to be Good for Victims of Dementia
Cholinesterase inhibitors, that help victims of Alzheimer's disease can also assist in the management of behavioural and psychological symptoms of dementia, a new study has shown.
Advertisement
 New Study Found Statins to Help Prevent AlzheimersStatins, the anti-cholesterol drugs, may help prevent the brain damage that leads to Alzheimer's disease, a new US study has found. | Advertisement
|
Advertisement
Recommended Readings
Latest Research News
Researchers develop a breakthrough “RNA monitoring” method that enables early detection of infant atopic dermatitis, a condition that is otherwise difficult to diagnose.
Researchers are working on new strategies and solutions for sleep apnea to ward off a range of health risks including cognitive decline.
The scientists discovered that when the stem cells in the hair follicle are made softer, they have a higher chance of growing hair.
A combinatorial therapy provided promising beneficial results among people with ischemic stroke.
In Parkinson's disease patients voice disorders are quite common. A new combination therapy had greater effects on the voice.